Viatris, which markets the product, called in HSD after a non-competitive pitch for a UK campaign. The agency will also support its activities at European conferences.
The consumer programme will highlight the benefits of Novolizer in terms of ease of use and drug delivery, while promoting better understanding of asthma and highlighting the importance of medication in managing symptoms.
The medical comms campaign will target respiratory experts and GPs, as well as nurses.
The agency is working for Viatris Pharmaceuticals, the UK affiliate of the Germany-based pharma firm.